Alec Stranahan

Stock Analyst at B of A Securities

(0.84)
# 3,959
Out of 5,044 analysts
31
Total ratings
41.67%
Success rate
-23.93%
Average return
Main Sectors:

Stocks Rated by Alec Stranahan

Krystal Biotech
Oct 17, 2025
Maintains: Buy
Price Target: $182$255
Current: $189.65
Upside: +34.46%
Candel Therapeutics
Sep 3, 2025
Downgrades: Neutral
Price Target: $13$7
Current: $5.60
Upside: +25.00%
Xencor
Sep 3, 2025
Downgrades: Neutral
Price Target: $23$12
Current: $14.25
Upside: -15.79%
Erasca
Sep 3, 2025
Downgrades: Underperform
Price Target: $4$1
Current: $2.44
Upside: -59.02%
Novavax
Aug 20, 2025
Downgrades: Underperform
Price Target: $9$7
Current: $8.52
Upside: -17.84%
Beam Therapeutics
Mar 28, 2025
Upgrades: Buy
Price Target: $42
Current: $26.43
Upside: +58.91%
Day One Biopharmaceuticals
Jan 7, 2025
Maintains: Buy
Price Target: $28$25
Current: $7.33
Upside: +241.06%
Caribou Biosciences
Jan 7, 2025
Maintains: Buy
Price Target: $13$11
Current: $2.47
Upside: +345.34%
Perspective Therapeutics
Nov 25, 2024
Downgrades: Neutral
Price Target: $24$6
Current: $2.87
Upside: +109.06%
Editas Medicine
Aug 8, 2024
Upgrades: Buy
Price Target: $13$15
Current: $3.17
Upside: +373.19%
Maintains: Buy
Price Target: $48$55
Current: $58.17
Upside: -5.45%
Maintains: Underperform
Price Target: $5$6
Current: $34.55
Upside: -82.63%